Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.25 | 6.89 |
| PEG Ratio (TTM) | -0.01 | -0.57 |
| P/S Ratio (TTM) | 0.12 | 5.34 |
| P/B Ratio (TTM) | 0.47 | 17.70 |
| P/FCF Ratio (TTM) | -1.09 | 17.43 |
| Price to 5YR AVG Earnings Ratio | N/A | 25.65 |
| Price to 5YR AVG FCF Ratio | N/A | 14.34 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -37.86% | 5.55% |
| ROE (TTM) | -145.10% | 54.04% |
| Net Profit Margin (TTM) | -48.94% | -139.23% |
| ROIC 5YR AVG | N/A | 7.95% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.85% | 84.80% | N/A |
| Revenue | 0.60% | 4.43% | N/A |
| Net Income | 10.73% | 86.99% | N/A |
| Cash Flow | -560.27% | 447.98% | N/A |
Health (11%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.10 | 1.62 |
| Quick Ratio (TTM) | 0.82 | 1.36 |
| D/E Ratio (TTM) | 1.55 | 1.51 |
| Interest Coverage (TTM) | -18.38 | 8.40 |
| Piotroski F-Score | 1 | 6 |
| Altman Z-Score | N/A | 5.62 |
| LTL to 5YR AVG FCF | N/A | 1.59 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.13% |